Status:
RECRUITING
Myval Global Study of Myval™ THV Series Implanted in Patients With Native Severe Aortic Valve Stenosis.
Lead Sponsor:
Meril Life Sciences Pvt. Ltd.
Conditions:
Aortic Valve Stenosis
Eligibility:
All Genders
18+ years
Brief Summary
A retrospective, multinational, multicentre, observational study in patients presenting with native severe aortic valve stenosis and treated with Myval™ Transcatheter Heart Valve Series in real-world ...
Detailed Description
Myval Global Study: A retrospective, multicentre, observational study in patients presenting with native severe aortic valve stenosis and treated with Myval™ Transcatheter Heart Valve Series in real-w...
Eligibility Criteria
Inclusion
- All patients of this study must have received Myval™ THV series for treatment of native severe aortic stenosis and completed a minimum of 30-day follow-up.
Exclusion
- No
Key Trial Info
Start Date :
August 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2028
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04703699
Start Date
August 7 2020
End Date
November 30 2028
Last Update
March 4 2024
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
North Estonia Medical center
Tallinn, Estonia
2
Clinical Institute Saint Ambrogio
Milan, Italy, 20149
3
Amphia Ziekenhui
Breda, North Brabant, Netherlands, 4818
4
University of Gdansk
Gdansk, Bażyńskiego, Poland, 80-309